TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

详细信息    查看全文

• 作者：D. Ferraro ; D. Goldstein ; R. L. O’Connell…
• 刊名：Cancer Chemotherapy and Pharmacology
• 出版年：2016
• 出版时间：August 2016
• 年：2016
• 卷：78
• 期：2
• 页码：361-367
• 全文大小：421 KB
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomediciner>Cancer Researchr>Pharmacology and Toxicologyr>Oncologyr>
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-0843
• 卷排序：78

文摘

Purpose The phase II TACTIC trial prospectively selected patients with KRAS wild-type advanced biliary tract cancer for first-line treatment with panitumumab and combination chemotherapy.